PT-2006-6094 · Oracle · Oracle Pharmaceutical Applications

Publicado 2006-10-18 · Atualizado 2018-10-17 · CVE-2006-5374

Positive Technologies (AI Summary)

CVSS v2.0

10

Alta

Vetor base

AV:N/AC:L/Au:N/C:C/I:C/A:C

Name of the Vulnerable Software and Affected Versions Oracle Pharmaceutical Applications version 4.5.1

Description The issue concerns an unspecified vulnerability with remote authenticated attack vectors. The impact of this issue is unknown.

Recommendations For Oracle Pharmaceutical Applications version 4.5.1, at the moment, there is no information about a newer version that contains a fix for this vulnerability.

Identificadores relacionados

CVE-2006-5374

Produtos afetados

Oracle Pharmaceutical Applications

Referências · 9

• http://securityfocus.com/archive/1/449711/100/0/threaded · Aviso do Fabricante
• http://secunia.com/advisories/22396 · Nota
• http://vupen.com/english/advisories/2006/4065 · Nota
• http://us-cert.gov/cas/techalerts/TA06-291A.html · Nota
• http://securitytracker.com/id?1017077 · Nota
• http://red-database-security.com/advisory/oracle_cpu_oct_2006.html · Nota
• http://securityfocus.com/bid/20588 · Correção
• http://oracle.com/technetwork/topics/security/cpuoct2006-095368.html · Nota
• https://nvd.nist.gov/vuln/detail/CVE-2006-5374 · Nota de Segurança